from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0478/deoC

LFCtreatmentdescriptionclass of inhibitor

-0.616

Amikacinug/mL Amikacintranslation

0.004

Cap5-10ug/mL Capreomycintranslation

0.782

Rox10-50 ug/mL Roxithromycintranslation

-0.220

SM2-5 ug/mL Streptomycintranslation

0.236

Tet5-10 ug/mL Tetracyclinetranslation

-0.403

Rif0.2-5ug/mL Rifampicintranscription

-1.317

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.794

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.980

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.345

CPZ10-50 ug/mL Chlorpromazinerespiration

0.265

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.752

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.682

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.185

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.758

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.038

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.083

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.010

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.117

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.651

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.905

KCN5-20 ug/mL Potassium cyaniderespiration

-0.650

NaN30.2-2 mM Sodium aziderespiration

-0.373

Nigericin50 uM Nigericinrespiration

-0.174

TRC10-150 ug/mL Triclosanrespiration

1.139

TRZ10-25 ug/mL Thioridazinerespiration

2.320

Valinomycin0.5-10 uM Valinomycinrespiration

-1.588

ZnSO42 mM ZnSO4respiration

-0.470

menadione6-10 ug/mL Menadionerespiration

0.233

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.588

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.502

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.888

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.420

NRP_1Non-replicating persistence stage 1dosRassociated

-0.232

Amp0.2mg/mL AmpicillincellWall

-0.382

Cephalexin20-100 ug/mL CephalexincellWall

-0.782

Cerulenin0.32-5 ug/mL CerulenincellWall

0.174

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.308

EMB10-20 ug/mL EthambutolcellWall

-0.419

Eta12-40 ug/mL EthionamidecellWall

-0.124

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.371

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.667

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.941

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.159

BZA0.12 mg/mL BenzamidearomaticAmides

-0.449

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.358

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.077

H2O24 mM hydrogen peroxideDNAdamaging

-0.519

Levo10 ug/mL LevofloxacinDNAdamaging

-0.258

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.440

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.260

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.274

UVUV-irradiationDNAdamaging

1.817

ARP41-4 ug/mL Antitubercular compound ARP4?

0.135

Antimycin12.5-50 ug/mL Antimycin A?

-0.159

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.019

PA_110-50 ug/mL Antitubercular compound PA-1?

0.778

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.754

PA8240.2-2 ug/mL PA-824?

1.211

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.588

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.173

Verapamil50 uM Verapamil?

-0.478

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.431

methoxatin10-20 ug/mL Methoxatin?